Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Hansoh Pharmaceutical Group Company Limited
  6. Summary
    3692   KYG549581067

HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED

(3692)
  Report
Delayed Hong Kong Stock Exchange  -  03:08:35 2023-02-01 am EST
16.30 HKD   +1.62%
01/18Four Hansoh Pharmaceutical Drugs Included in China's National Reimbursement Drug List
MT
01/17Chinese Regulator Grants Clinical Trial Approval to Hansoh Pharmaceuticals' Anti-SARS-CoV-2 Tablets
MT
01/17Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Approval of Oral Small Molecule 3CL Protease Inhibitor
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Hong Kong Stock Exchange
01/26/2023 01/27/2023 01/30/2023 01/31/2023 02/01/2023 Date
17.1(c) 17.28(c) 16.12(c) 16.04(c) 16.3(c) Last
2 590 371 1 511 755 5 776 401 8 341 911 2 843 349 Volume
+1.79% +1.05% -6.71% -0.50% +1.62% Change
More quotes
Estimated financial data (e)
Sales 2022 10 188 M 1 509 M 1 509 M
Net income 2022 2 828 M 419 M 419 M
Net cash position 2022 16 043 M 2 375 M 2 375 M
P/E ratio 2022 29,1x
Yield 2022 0,55%
Sales 2023 11 584 M 1 715 M 1 715 M
Net income 2023 3 173 M 470 M 470 M
Net cash position 2023 17 646 M 2 613 M 2 613 M
P/E ratio 2023 26,0x
Yield 2023 0,64%
Capitalization 81 826 M 12 115 M 12 115 M
EV / Sales 2022 6,46x
EV / Sales 2023 5,54x
Nbr of Employees 10 783
Free-Float 18,1%
More Financials
Company
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED is a China-based investment holding company principally involved in the the research and development, production and sale of pharmaceutical products. The Company’s main products include Oulanning, Ameining, Pulaile, Zefei, Xinwei, Xinmei, Zetan, Mailingda, Hengjie, Hengsen, Fulaidi and Ruibote, among others. The Company’s products are mainly used for central nervous... 
Read more
Sector
Pharmaceuticals
Calendar
03/28Earnings Release
More about the company
Ratings of Hansoh Pharmaceutical Group Company Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
01/18Four Hansoh Pharmaceutical Drugs Included in China's National Reimbursement Drug List
MT
01/17Chinese Regulator Grants Clinical Trial Approval to Hansoh Pharmaceuticals' Anti-SARS-C..
MT
01/17Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Approval of Oral S..
CI
01/09Hansoh Pharmaceutical Gets Regulatory OK for Glomerulosclerosis, Immunoglobulin A Nephr..
MT
01/09Hansoh Pharmaceutical Group Company Limited Announces That " Hs-10390 Tablets " Has Bee..
CI
2022Chinese Regulator Grants Clinical Trial Notice to Hansoh Pharmaceutical's Solid Tumors ..
MT
2022Hansoh Pharmaceutical Group Company Limited Announces Clinical Trial Notice of "HS-1050..
CI
2022Easing of Hong Kong Travel Strictures Sends Market Higher
MT
2022European Regulator Accepts Hansoh Pharmaceutical Partner's Marketing Application for Lu..
MT
2022Hansoh Pharmaceutical Group Company Limited Announces European Medicines Agency Accepts..
CI
2022Hansoh Pharmaceutical Unit Signs Drug Licensing Deal with Biotheus
MT
2022Hong Kong Hang Seng Up 1% on Central Bank Outlooks
MT
2022Hong Kong Hang Seng Down 1.4% to Hit 13-Year Low
MT
2022Hong Kong stocks slip on China concerns after sharp rally
RE
2022KiOmed Pharma and Hansoh Pharma Announce License Agreement for KioMedinevsone in China'..
AQ
More news
News in other languages on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
01/19La actualización de la Lista Nacional de Medicamentos Reembolsables de China cumple las..
01/17Hansoh Pharmaceutical Group Company Limited annonce l'approbation de l'essai clinique d..
01/09Hansoh Pharmaceutical Group Company Limited annonce que les comprimés " Hs-10390 " ont ..
2022Hansoh Pharmaceutical Group Company Limited annonce l'avis d'essai clinique des "compri..
2022L'assouplissement des restrictions sur les voyages à Hong Kong fait grimper le marché
More news
Analyst Recommendations on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
More recommendations
ETFs positioned on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Loncar China BioPharma ETF - Distributing - USD2.15%-2.76%China
Global X MSCI China Health Care ETF - USD2.12%-5.82%China
KraneShares Emerging Market Healthcare Inde...1.11%-2.03%NC
KraneShares MSCI All China Health Care Inde...1.09%-5.99%China
Global X Longevity Thematic ETF - USD0.75%-1.48%World
More ETFs positioned on HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Chart HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Duration : Period :
Hansoh Pharmaceutical Group Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 13,82 CNY
Average target price 17,56 CNY
Spread / Average Target 27,0%
EPS Revisions
Managers and Directors
Hui Juan Zhong Chairman & Chief Executive Officer
Guo Qiang Lin Independent Non-Executive Director
Sheung Wai Chan Independent Non-Executive Director
Dong Tao Yang Independent Non-Executive Director
Ai Feng Lyu Executive Director
Sector and Competitors
1st jan.Capi. (M$)
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED8.09%12 115
JOHNSON & JOHNSON-7.49%427 259
ELI LILLY AND COMPANY-6.93%327 004
NOVO NORDISK A/S0.53%310 851
ROCHE HOLDING AG-1.81%274 452
MERCK & CO., INC.-3.19%272 327